Subscribe to Drug Discovery & Development News

The Lead

Nanoparticle Therapy Promotes Wound Healing

March 27, 2015 | by Yeshiva University | Comments

An experimental therapy can cut in half the time it takes to heal wounds compared to no treatment at all. Read more...

View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Cells Rebound after Treatment for Most Children with HIV, Low Immune Cell Count

March 27, 2015 2:13 pm | by Enrique Rivero, UCLA | Comments

Most children with HIV who have low levels of a key immune cell eventually recover levels of this cell after they begin treatment. Read more...

White House Releases Plan to Fight Antibiotic Resistance

March 27, 2015 12:58 pm | by Stephanie Guzowski, Editor | Comments

The White House has revealed today its comprehensive plan to tackle antibiotic resistance within the next five years, according to a copy of the 60-page report, which was reviewed by Reuters. Read more...


Researchers Create Method for Measuring Early Sign of Alzheimer's

March 27, 2015 10:36 am | by UCLA | Comments

After six years of painstaking research, a UCLA-led team has validated the first standardized protocol for measuring one of the earliest signs of Alzheimer’s disease — the atrophy of the part of the brain known as the hippocampus. Read more...


Indiana Governor Overrides Law to Authorize Needle Exchange

March 27, 2015 10:32 am | by Rick Callahan, AP | Comments

Indiana Gov. Mike Pence overrode state law and his own anti-drug policies Thursday to authorize a short-term needle-exchange program designed to help contain HIV infections in a rural county where more than six dozen cases have been reported, all of them tied to intravenous drug use. Read more...


Roseroot Shows Promise as Potential Depression Treatment Option

March 27, 2015 10:27 am | by Penn University | Comments

Rhodiola rosea (R. rosea), or roseroot, may be a beneficial treatment option for major depressive disorder (MDD), according to results of a study in the journal Phytomedicine. Read more...


Gelesis Closes $22M Equity Financing

March 27, 2015 10:21 am | Comments

Gelesis, a clinical stage biotechnology company focused on the development of first-in-class products to induce weight loss and improve glycemic control, announced today that it closed an equity financing of shares of convertible preferred stock for gross proceeds of approximately $22 million. Read more...


Precision Medicine Shaping the Future of Cancer Research

March 27, 2015 8:41 am | by Columbia University | Comments

Nearly 50 years after the “war on cancer” was declared in the United States, precision medicine presages an era of increased understanding of the molecular basis of cancer and of the ability to design treatments. Read more...

Sierra Leoneans to Stay Home in Final Push to Stop Ebola

March 27, 2015 8:32 am | by Clarence Roy-Macaulay, Associated Press | Comments

Sierra Leone's 6 million people were told to stay home for three days, except for religious services, beginning Friday as the West African nation attempted a final push to rid itself of Ebola. Read more...


Novo Nordisk Resubmits NDA for Tresiba, Ryzodeg in U.S.

March 26, 2015 4:38 pm | Comments

The resubmission is expected to take place within the next month. Read more...


Takeda's NDA for Type 2 Diabetes Drug Gets Japanese Approval

March 26, 2015 4:26 pm | Comments

Zafatek is a once-weekly DPP-4 inhibitor.


Cane Toads Potentially Lucrative Export in Cancer Fight

March 26, 2015 4:12 pm | by University of Queensland | Comments

Scientists are exploring how cane toad venom can be used to fight cancer. Read more...


Multistate Investigation Announced into Premera Cyberattack

March 26, 2015 2:10 pm | by Derrick Nunnally, Associated Press | Comments

Washington state's insurance commissioner announced a multistate investigation into this winter's cyberattack on Premera Blue Cross. Read more...


HIV Replicates in Brain Earlier than Thought: Study

March 26, 2015 2:05 pm | by Stephanie Guzowski, Editor | Comments

A recent study, funded by the National Institutes of Health (NIH), highlights the importance of HIV screening and beginning antiretroviral therapy (ART) as early as possible. The analysis of cerebral spinal fluid (CSF), which illuminates brain chemical activity, showed that HIV can begin replicating in a patient’s brain as early as four months after infection. Read more...


Stemedica: Worldwide License for Stem Cell Stabilization Technologies

March 26, 2015 1:41 pm | Comments

Stemedica Cell Technologies Inc., (Stemedica), announced that Universal Stabilization Technologies (UST) has granted to Stemedica subsidiary StemProtein, LLC, an exclusive worldwide license to its technology known as Preservation by Vaporization (PBV). Read more...


New Autism-Causing Genetic Variant Identified

March 26, 2015 1:35 pm | by Johns Hopkins | Comments

Using a novel approach that homes in on rare families severely affected by autism, a Johns Hopkins-led team of researchers has identified a new genetic cause of the disease. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.